Viewing Study NCT00090116

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:45 AM
Ignite Modification Date: 2026-05-26 @ 6:41 AM
Study NCT ID: NCT00090116
Status: COMPLETED
Last Update Posted: 2012-03-05
First Post: 2004-08-24
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease
Sponsor: Forest Laboratories
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Alzheimer's Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neramexane View
None NMDA receptor antagonist View
None Memory Loss View
None Alzheimer Disease View